F

FATE

Fate Therapeutics Inc

2.84

Aug 13 • 7:42 AM ET +0.12 (4.41%)

Healthcare Biotechnology USA Small NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX ZNTL REPL

| Held by: VTI VXF SCHA IWC VHT PRFZ BUSM SCHB AVSC DFMC

Scroll to Statements

Index	-
Market Cap	331.03M
Enterprise Value	232.99M
Income	-129.91M
Sales	6.32M
Book/sh	1.55
Cash/sh	1.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	161
IPO	Oct 01, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	52.38
P/B	1.84
P/C	1.89
P/FCF	-
EV/EBITDA	-
EV/Sales	36.87
Quick Ratio	5.85
Current Ratio	5.85
Debt/Eq	0.43
LT Debt/Eq	0.40
Option/Short	Yes / Yes

EPS (ttm)	-1.09
EPS next Y	-1.03
EPS next Q	-0.27
EPS this Y	5.93%
EPS next Y	4.70%
EPS next 5Y	2.41%
EPS past 3/5Y	26.67% 11.42%
Sales past 3/5Y	-58.98% -26.71%
EPS Y/Y TTM	26.97%
Sales Y/Y TTM	-52.64%
EPS Q/Q	18.19%
Sales Q/Q	-20.26%
Earnings	May 13 BMO
EPS/Sales Surpr.	7.14% -12.93%

Insider Own	5.08%
Insider Trans	-2.27%
Inst Own	55.38%
Inst Trans	3.33%
ROA	-38.01%
ROE	-55.50%
ROIC	-51.60%
Gross Margin	-97.69%
Oper. Margin	-2207.47%
Profit Margin	-2056.79%
SMA20	9.22%
SMA50	14.18%
SMA200	75.16%
Trades

Shs Outstand	116.27M
Shs Float	110.63M
Short Float	6.94%
Short Ratio	2.03
Short Interest	7.68M
52W High	3.23 -12.07%
52W Low	0.93 204.23%
Volatility	7.33% 7.32%
ATR (14)	0.20
RSI (14)	59.24
Beta	2.57
Rel Volume	0.01
Avg Volume	3.79M
Volume	2,500

Perf Week	14.06%
Perf Month	-5.02%
Perf Quarter	33.02%
Perf Half Y	142.74%
Perf YTD	189.03%
Perf Year	151.33%
Perf 3Y	-8.09%
Perf 5Y	-96.72%
Perf 10Y	10.94%
Recom	2.00
Target Price	5.41
Prev Close	2.72
Price	2.84
Change %	4.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)